Sema3A Inhibits Osteolytic Bone Metastasis of Non-small Cell Lung Cancer
CONCLUSION: This study provides a new idea for the clinical treatment of osteolytic bone metastasis in NSCLC.PMID:38629364 | DOI:10.2174/0115748928295263240402085411
Source: Recent Patents on Anti-Cancer Drug Discovery - Category: Cancer & Oncology Authors: Wei Wang Kaicheng Shen Ruyan Liu Qi Zhou Source Type: research
More News: Cancer | Cancer & Oncology | Lung Cancer | Non-Small Cell Lung Cancer | Orthopaedics | Pain | Study